Evidence map›Paper›PMID 11498504›Full record

ArticleBritish journal of pharmacology2001

Evidence that the anti-spasmogenic effect of the beta-adrenoceptor agonist, isoprenaline, on guinea-pig trachealis is not mediated by cyclic AMP-dependent protein kinase.

L Spicuzza, M G Belvisi, M A Birrell, P J Barnes, D J Hele, M A Giembycz

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 42 citations in OpenAlex.

  1. Antispasmodic, cardioprotective and blood-pressure lowering properties ofJournal of traditional and complementary medicine · 2024
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Prostaglandin EMolecular pharmacology · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. cAMP regulation of airway smooth muscle function.Pulmonary pharmacology & therapeutics · 2013
    Review
  12. Article
  13. Epac as a novel effector of airway smooth muscle relaxation.Journal of cellular and molecular medicine · 2011
    Article
  14. Article
  15. Anti-mitogenic effects of β-agonists and PGE2 on airway smooth muscle are PKA dependent.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2011
    Article
  16. Regulation of heterotrimeric G protein signaling in airway smooth muscle.Proceedings of the American Thoracic Society · 2008
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

L SpicuzzaDepartment of Thoracic Medicine, Imperial College School of Medicine, National Heart & Lung Institute, Dovehouse Street, London SW3 6LY.
M G Belvisi
M A Birrell
P J Barnes
D J Hele
M A Giembycz
Lung Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

1. The spasmolytic and anti-spasmogenic activity of beta-adrenoceptor agonists on airways smooth muscle is thought to involve activation of the cyclic AMP/cyclic AMP-dependent protein kinase (PKA) cascade. Here we have tested the hypothesis that PKA mediates the anti-spasmogenic activity of isoprenaline and other cyclic AMP-elevating agents in guinea-pig isolated trachea by utilizing a number of cell permeant cyclic AMP analogues that act as competitive 'antagonists' of PKA. 2. Anion-exchange chromatography of guinea-pig tracheae resolved two peaks of PKA activity that corresponded to the type I ( approximately 5%) and type II ( approximately 93%) isoenzymes. 3. Pre-treatment of tracheae with zardaverine (30 microM), vasoactive intestinal peptide (VIP) (1 microM) and the non-selective activator of PKA, Sp-8-CPT-cAMPS (10 microM), produced a non-parallel rightwards shift in the concentration-response curves that described acetylcholine (ACh)-induced tension generation. The type II-selective PKA inhibitor, Rp-8-CPT-cAMPS (300 microM), abolished this effect. 4. Pre-treatment of tracheae with Sp-8-Br-PET-cGMPS (30 microM) produced a non-parallel rightwards shift of the concentration-response curves that described ACh-induced tension generation. The selective cyclic GMP-dependent protein kinase (PKG) inhibitor, Rp-8-pCPT-cGMPS (300 microM), abolished this effect. 5. Pre-treatment of tracheae with isoprenaline (1 microM) produced a 10 fold shift to the right of the ACh concentration-response curve by a mechanism that was unaffected by Rp-8-Br-cAMPS (300 microM, selective inhibitor of type I PKA), Rp-8-CPT-cAMPS (300 microM) and Rp-8-pCPT-cGMPS (300 microM). 6. We conclude that the anti-spasmogenic activity of Sp-8-CPT-cAMPS, zardaverine and VIP in guinea-pig trachea is attributable to activation of the cyclic AMP/PKA cascade whereas isoprenaline suppresses ACh-induced contractions by a mechanism(s) that is independent of PKA and PKG.

Indexed as

AcetylcholineAdrenergic beta-AgonistsAnimalsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Dependent Protein Kinase Type IICyclic GMPCyclic GMP-Dependent Protein KinasesGuinea PigsIsoenzymesIsoproterenolMuscle ContractionMuscle, SmoothMuscle TonusPyridazinesTracheaAcetylcholineAdrenergic beta-AgonistsCyclic AMPCyclic AMP-Dependent Protein KinasesCyclic AMP-Dependent Protein Kinase Type IICyclic GMPCyclic GMP-Dependent Protein KinasesIsoenzymesIsoproterenolPyridazineszardaverine

Identifiers

PMID11498504
PMCPMC1621162
OpenAlexW2049215234

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.